INFUSE BONE GRAFT

Device Medtronic, Inc.
Total Payments
$4.4M
Transactions
1,389
Doctors
126
Companies
1

Payment Trends by Year

Year Amount Transactions Doctors
2024 $2.0M 594 58
2023 $1.2M 326 34
2022 $1.3M 469 59

Payments by Nature

Nature of Payment Amount Transactions Share
Unspecified $3.9M 928 90.0%
Consulting Fee $177,542 24 4.0%
Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program $125,100 33 2.8%
Grant $90,918 53 2.1%
Travel and Lodging $35,843 148 0.8%
Food and Beverage $10,351 203 0.2%

Payments by Type

Research
$3.9M
928 transactions
General
$439,754
461 transactions

Research Studies & Clinical Trials

Study Name Sponsor Amount Doctors
TLIF IDE Pivotal Study Medtronic, Inc. $3.3M 3
(P16-03) INFUSE PLF Medtronic, Inc. $660,424 0

Top Doctors Receiving Payments for INFUSE BONE GRAFT — Page 6

Doctor Specialty Location Total Records
, M.D Neurological Surgery Bloomington, IN $5.15 1
, MD Orthopaedic Surgery of the Spine Chattanooga, TN $2.83 1
«1…456

Manufacturing Companies

Product Information

  • Type Device
  • Total Payments $4.4M
  • Total Doctors 126
  • Transactions 1,389

About INFUSE BONE GRAFT

INFUSE BONE GRAFT is a device associated with $4.4M in payments to 126 healthcare providers, recorded across 1,389 transactions in the CMS Open Payments database. The primary manufacturer is Medtronic, Inc..

Payment data is available from 2022 to 2024. In 2024, $2.0M was paid across 594 transactions to 58 doctors.

The most common payment nature for INFUSE BONE GRAFT is "Unspecified" ($3.9M, 90.0% of total).

INFUSE BONE GRAFT is associated with 2 research studies, including "TLIF IDE Pivotal Study" ($3.3M).